These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16637920)

  • 1. Thymus and myasthenia gravis: antigen processing in the human thymus and the consequences for the generation of autoreactive T cells.
    Melms A; Luther C; Stoeckle C; Pöschel S; Schroth P; Varga M; Wienhold W; Tolosa E
    Acta Neurol Scand Suppl; 2006; 183():12-3. PubMed ID: 16637920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteases, processing, and thymic selection.
    Cresswell P
    Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
    [No Abstract]   [Full Text] [Related]  

  • 3. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.
    Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D
    J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.
    Nakagawa T; Roth W; Wong P; Nelson A; Farr A; Deussing J; Villadangos JA; Ploegh H; Peters C; Rudensky AY
    Science; 1998 Apr; 280(5362):450-3. PubMed ID: 9545226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
    J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc gamma receptors and HLA-DR antigens on thymus cells in myasthenia gravis.
    Gilhus NE; Matre R
    J Neuroimmunol; 1986 Jan; 10(3):271-8. PubMed ID: 2934405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis.
    Aarli JA; Heimann P; Matre R; Thunold S; Tönder O
    J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):29-34. PubMed ID: 310870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
    Schulz R; Mellor AL
    J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered intrathymic T-cell repertoire in human myasthenia gravis.
    Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
    Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.
    Nicolle MW; Nag B; Sharma SD; Willcox N; Vincent A; Ferguson DJ; Newsom-Davis J
    J Clin Invest; 1994 Apr; 93(4):1361-9. PubMed ID: 7512979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thymus in myasthenia gravis: an immunohistologic study.
    Kornstein MJ; Brooks JJ; Anderson AO; Levinson AI; Lisak RP; Zweiman B
    Adv Exp Med Biol; 1985; 186():929-36. PubMed ID: 2413737
    [No Abstract]   [Full Text] [Related]  

  • 14. Cathepsin S dominates autoantigen processing in human thymic dendritic cells.
    Stoeckle C; Quecke P; Rückrich T; Burster T; Reich M; Weber E; Kalbacher H; Driessen C; Melms A; Tolosa E
    J Autoimmun; 2012 Jun; 38(4):332-43. PubMed ID: 22424724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactivity between lymphocytes and thymus cells in myasthenia gravis.
    Opelz G; Keesey J; Glovsky MM; Gale RP
    Arch Neurol; 1978 Jul; 35(7):413-5. PubMed ID: 149529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
    Fujii Y; Hayakawa M; Inada K; Nakahara K
    Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.
    Honey K; Nakagawa T; Peters C; Rudensky A
    J Exp Med; 2002 May; 195(10):1349-58. PubMed ID: 12021314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
    Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
    Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
    Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
    Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
    Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A
    Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.